Calamari Christopher J. 4
4 · ABBOTT LABORATORIES · Filed Jul 6, 2021
Insider Transaction Report
Form 4
Calamari Christopher J.
SENIOR VICE PRESIDENT
Transactions
- Award
Option (right to buy)
2021-07-01+19,291→ 19,291 totalExercise: $116.40From: 2022-07-01Exp: 2031-06-30→ Common Shares (19,291 underlying) - Award
Common shares without par value
2021-07-01+3,764→ 15,920 total
Holdings
- 30,193(indirect: By Trust)
Common shares without par value
- 100(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of July 1, 2021.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 6,430 on July 1, 2022, 6,430 on July 1, 2023 and 6,431 on July 1, 2024.